Edition:
India

Harbin Pharmaceutical Group Co Ltd (600664.SS)

600664.SS on Shanghai Stock Exchange

5.42CNY
26 Mar 2019
Change (% chg)

¥0.25 (+4.84%)
Prev Close
¥5.17
Open
¥5.27
Day's High
¥5.42
Day's Low
¥5.13
Volume
101,506,923
Avg. Vol
22,107,984
52-wk High
¥5.65
52-wk Low
¥3.27

Latest Key Developments (Source: Significant Developments)

Harbin Pharmaceutical's Controlling Shareholder To Restart Plan Related To Mixed Ownership Reform
Monday, 12 Nov 2018 

Nov 12 (Reuters) - Harbin Pharmaceutical Group Co Ltd <600664.SS>::SAYS CONTROLLING SHAREHOLDER TO RESTART ITS PLAN RELATED TO MIXED OWNERSHIP REFORM, NO DIRECT IMPACT TO COMPANY'S DAILY OPERATION.  Full Article

State Asset Regulator Halts Harbin Pharma Controller Shareholder's Plan To Boost Its Capital Via Share Issue
Thursday, 21 Jun 2018 

June 21 (Reuters) - Harbin Pharmaceutical Group Co Ltd <600664.SS>::SAYS STATE ASSET REGULATOR TERMINATES CONTROLLING SHAREHOLDER'S PROPOSAL TO BOOST CAPITAL VIA SHARE ISSUE.SAYS CITIC CAPITAL TO SCRAP ITS PLAN TO ACQUIRE THE COMPANY.  Full Article

Harbin Pharmaceutical Group to pay 2017 A share dividend on May 4
Wednesday, 25 Apr 2018 

April 25(Reuters) - Harbin Pharmaceutical Group Co Ltd <600664.SS>:Says it will pay a cash dividend of 0.5 yuan per share (before tax) for 2017, to shareholders of A share recorded on May 3.Says the company's shares will be traded ex-right and ex-dividend on May 4 and the dividend will be paid on May 4 .  Full Article

Harbin Pharmaceutical Group says change of accounting policy
Monday, 12 Feb 2018 

Feb 12(Reuters) - Harbin Pharmaceutical Group Co Ltd <600664.SS> ::Says it changed the accounting policy due to national policy requirement.  Full Article

Harbin Pharmaceutical's 9-month net profit down 56.8 pct y/y
Thursday, 26 Oct 2017 

Oct 26 (Reuters) - Harbin Pharmaceutical Group Co Ltd <600664.SS>:Says 9-month net profit down 56.8 percent y/y.  Full Article

REFILE-BRIEF-Harbin Pharmaceutical Signs Agreement With Israel's Teva Pharmaceutical Industries

* SAYS IT SIGNS AUTHORIZATION AND DISTRIBUTION AGREEMENT WITH ISRAEL'S TEVA PHARMACEUTICAL INDUSTRIES, EXPECTS INVESTMENT OF ABOUT 160 MILLION YUAN Source text in Chinese: https://bit.ly/2PdGwJL Further company coverage: (Reporting by Hong Kong newsroom)